Literature DB >> 28246760

[Side effects of pain therapy : Sufficient analgesia without unnecessary complications].

F Greul1, A Zimmer2, W Meißner2.   

Abstract

Interventions of acute and chronic pain treatment are associated with risks. Therefore, it is important to know about treatment side effects in order to avoid unnecessary complications and therapy interruption. This knowledge, however, is not to prevent/abandon this treatment altogether. Rather, it is intended to use pain treatment interventions rationally. The following article is to deepen the knowledge of unintended effects of analgetic treatments. Moreover, it will help find an optimal pain therapy in terms of efficacy and tolerable risks as well as limitations. Nonopiates have organ toxic side effects. It is imperative to observe the maximum daily dose and comorbidity. Opioids can have either central or peripheral side effects. Patients suffer, among others, from addiction, breath depression, and tolerance as well as from obstipation, concentration disorders, and an increased risk of falling. Psychiatric drugs, corticosteroids, ketamine, bisphosphonates, and lidocaine are co-analgetics. Besides adverse effects connected to their specific substances, these drugs have partially additive effects on complications of classic analgetics (e. g., gastrointestinal ulceration, renal insufficiency, constipation, and concentration deficits). Invasive procedures (such as epidural catheter) call for an interdisciplinary collaboration. To know about unintended effects helps to avoid dramatic complications (e. g., paraplegia). A sufficient pain therapy, therefore, is more than sufficient analgesia. It also includes the reduction of side effects and complications.

Entities:  

Keywords:  Co-analgetics; Nerve stimulation; Nonopioid analgesics; Opioid analgesics; Quality of life

Mesh:

Substances:

Year:  2017        PMID: 28246760     DOI: 10.1007/s00120-017-0337-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  29 in total

1.  Systemic local-anaesthetic-type drugs in chronic pain: a systematic review.

Authors: 
Journal:  Eur J Pain       Date:  1998-03       Impact factor: 3.931

Review 2.  The key role of bisphosphonates in the supportive care of cancer patients.

Authors:  Maria Tolia; Anna Zygogianni; John R Kouvaris; Christos Meristoudis; Niki Margari; Petros Karakitsos; Ioannis Kokakis; Dimitrios Kardamakis; Christos Papadimitriou; Kyriaki Mystakidou; Nikolaos Tsoukalas; George Kyrgias; Basil Armonis; Dimitrios K Filippiadis; Alexios D Kelekis; Nikolaos Kelekis; Vasileios Kouloulias
Journal:  Anticancer Res       Date:  2014-01       Impact factor: 2.480

Review 3.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 4.  Psychiatric agents and implications for perioperative analgesia.

Authors:  Blas Catalani; Craig S Hamilton; Edwin W Herron; Richard D Urman; Charles J Fox; Alan David Kaye
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2014-05-22

Review 5.  Principles of opioid use in cancer pain.

Authors:  Russell K Portenoy; Ebtesam Ahmed
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

Review 6.  Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs.

Authors:  Sonja Vuč Ković; Katarina Savić Vujović; Dragana Srebro; Branislava Medić; Tatjana Ilic-Mostic
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

7.  [Analgesic efficacy of TENS therapy in patients with gonarthrosis. A prospective, randomised, placebo-controlled, double-blind study].

Authors:  B Gschiel; H Kager; W Pipam; K Weichart; R Likar
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

Review 8.  [Epidural anesthesia].

Authors:  F Gerheuser; A Roth
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

Review 9.  Bone cancer pain: causes, consequences, and therapeutic opportunities.

Authors:  Patrick Mantyh
Journal:  Pain       Date:  2013-07-31       Impact factor: 6.961

10.  [Peridural application of ropivacaine and clonidine for pain therapy after prostatectomy].

Authors:  M Voje; A Manohin
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.